Table 1.
No. | Age (y)/Sex | Location | Size (cm) | Subtype | Mitoses/10 HPFs | Necrosis | Nuclear pleomorphism | INV | PA% |
---|---|---|---|---|---|---|---|---|---|
1 | 47/F | Parotid | 1.3 | MECA | 2 | No | No | WI | 15 |
2 | 41/M | Parotid | 9.5 | MECA | 1 | Yes | No | WI | <5 |
3 | 67/F | Parotid | 1.1 | MECA | 12 | No | Yes | WI | 10 |
4 | 77/M | BOT | 2.1 | MECA | 22 | Yes | No | WI | 15 |
5 | 67/F | Parotid | 6 | MECA | 5 | Yes | Yes | WI | <5 |
6r | 63/F | Parotid | NA | MECA | NA | NA | NA | NA | NA a |
7 | 64/M | Parotid | 3 | MECA | 2 | Yes | Yes | WI | NA a |
8 | F | Parotid | NA | MECA | 6 | Yes | No | WI | 20 |
9 | 76/M | Parotid | 3.5 | MECA | 7 | Yes | Yes | WI | 30 |
10 | NA | NA | NA | MECA | NA | NA | NA | NA | NA a |
11 | 67/F | Parotid | 4.2 | SDC | 16 | Yes | Yes | WI | 25 |
12 | 63/M | Parotid | 1.4 | SDC | 8 | Yes | Yes | WI | 10 b |
13 | 75/M | Parotid | 2 | SDC | 8 | Yes | No | WI | 60 |
14 | 67/F | Parotid | 4.4 | SDC | 3 | Yes | Yes | WI | 10 |
15 | 70/M | Parotid | 1.2 | SDC | 6 | Yes | No | WI | 15 |
16 | 51/M | Parotid | 3.4 | SDC | 20 | Yes | Yes | WI | 30 |
17 | 87/F | Parotid | 2.4 | SDC | 9 | Yes | Yes | WI | 5 b |
18 | 43/M | Parotid | 1.5 | SDC | 4 | Yes | Yes | WI | 30 |
19 | 68/F | Parotid | 2 | SDC | 3 | Yes | Yes | WI | 70 |
20 | 98/M | Parotid | 2.7 | SDC | 10 | Yes | Yes | WI | 5 b |
21 | 74/F | Lacrimal gland | 4.2 | CA-SG | 16 | Yes | Yes | WI | 25 |
22 | 35/M | Parotid | 5.8 | MECA and ACA NOS | 6 | Yes | Yes | NI | 40 |
Abbreviations: INV, invasion; BOT, base of tongue; NA, not available; PA, pleomorphic adenoma; MECA, myoepithelial carcinoma; SDC, salivary duct carcinoma; F, female; M, male; WI, widely invasive; BOT, base of tongue; NA: not applicable; CA-SG, carcinoma with squamoglandular features; ACA NOS, adenocarcinoma not otherwise specified; WI, widely invasive; NI, noninvasive.
The prior PA at the same site was not available for review.
Hyalinized nodule.